or
forgot password
  • cancer clinical trials in la jolla, CA

  • Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Endometrial Cancer, Fatigue, Neurotoxicity
    A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia
    Scripps Cancer Center
    La Jolla, California 92037
    Chronic Lymphocytic Leukemia, Leukemia
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    University of California San Diego
    La Jolla, California 92093
    Ovarian Cancer
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Lung Cancer
    Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)
    University of California San Diego Dept of Moores Cancer Ctr (3)
    La Jolla, California 92093-0658
    Gastrointestinal Stromal Tumor (GIST)
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    University of California at San Diego
    La Jolla, California 92093
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
    University of California, San Diego
    La Jolla, California 92037-1709
    Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Brain and Central Nervous System Tumors
    Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
    University of California at San Diego
    La Jolla, California 92093
    Atypical Endocervical Glandular Cell of Undetermined Significance, Atypical Endometrial Hyperplasia, Atypical Glandular Cell of Undetermined Significance, Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection
    Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
    University of California San Diego Dept of Moores Cancer Ctr (5)
    La Jolla, California 92093-0658
    Renal Cell Carcinoma
    Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Head and Neck Squamous Cell Carcinoma
    Effectiveness of a Blood Stem Cell Transplant That Uses Low Dose Chemotherapy in People With Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN #0701)
    University of California, San Diego (UCSD) Medical Center
    La Jolla, California 92093
    Lymphoma, Non-Hodgkin
    Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
    University of California San Diego Moores Cancer Center (UCSD)
    La Jolla, California 92093
    Glioblastoma Multiforme
    A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma
    University of California San Diego
    La Jolla, California 92093
    Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma
    A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
    Location# 019
    La Jolla, California 92093-0698
    Metastatic Colorectal Cancer
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Moores Cancer Center- UCSD
    La Jolla, California 92093
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Moores University of California San Diego Cancer Center
    LA Jolla, California 92093
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Scripps Polster Breast Care Center Investigational GeneBank
    Scripps Polster Breast Care Center
    La Jolla, California 92037
    Breast Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Lung Cancer
    PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients
    Scripps Clinic

    Trial Locations
    Scripps Clinic
    UCSD Medical Center BMT Program
    Lymphoma
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of California at San Diego
    La Jolla, California 92093
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Head and Neck Cancer
    Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
    La Jolla Village Family Medical Group
    La Jolla, California 92037
    Gaucher Disease
    Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
    Moores Cancer Center
    La Jolla, California 92093-0820
    Relapsed or Refractory Chronic Lymphocytic Leukemia
    Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    UCSD Moores Cancer Center
    La Jolla, California 93093
    Non-small Cell Lung Cancer
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    University of California at San Diego
    La Jolla, California 92093
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Brain and Central Nervous System Tumors, Neurotoxicity
    Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia
    Rebecca and John Moores UCSD Cancer Center

    Trial Locations
    Rebecca and John Moores UCSD Cancer Center
    UCSD Medical Center
    Acute Lymphoblastic Leukemia
    Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
    University of California San Diego La Jolla - UCSD Moores Cancer
    La Jolla, California 92093-0658
    HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    University of California at San Diego
    La Jolla, California 92093
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Brain and Central Nervous System Tumors
    A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
    University of California San Diego UCSD Moores Cancer Center
    La Jolla, California 92093-0658
    Melanoma
    A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
    Univ. of San Diego: Moores UCSD Cancer Center
    La Jolla, California 92093
    Leukemia
    I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
    University of California San Diego
    La Jolla, California 92093
    Breast Neoplasms, Breast Cancer, Breast Tumors
    Ovarian Cancer Vaccine for Patients in Remission
    Scripps Cancer Center
    La Jolla, California 92037
    Epithelial Ovarian Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    OTIS Autoimmune Diseases in Pregnancy Project
    University of California, San Diego
    La Jolla, California 92037-1709
    Crohn's Disease, Rheumatoid Arthritis
    An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Acute Myeloid Leukemia, Multiple Myeloma
    A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
    UCSD Medical Center

    Trial Locations
    UCSD Medical Center
    Thornton Hospital
    The Rebecca and John Moores UCSD Cancer Center
    Colorectal Neoplasms, Liver Neoplasms
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    Moores Cancer Center UCSD
    La Jolla, California
    Peripheral T-cell Lymphoma
    Reducing Breast Cancer Recurrence With Weight Loss
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Breast Cancer, Overweight, Obesity
    First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma
    Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Invasive Breast Cancer, Ductal Carcinoma in Situ
    Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas
    The Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093
    Glioma
    Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
    UCSD School of Medicine
    La Jolla, California 92093-0663
    PCOS
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of California at San Diego
    La Jolla, California 92093
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
    Moores UCSD Cancer Center

    Trial Locations
    Moores UCSD Cancer Center
    Scripps Clinical Research Services
    Ovarian Cancer
    Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
    University of California San Diego, Moores Cancer Center

    Trial Locations
    University of California San Diego, Moores Cancer Center
    Danelle James, M.D.
    CLL